Molecular pathways involved in the improvement of non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis are components of the metabolic syndrome. Serum leptin levels are elevated in obesity, but the role of leptin in the pathophysiology of the liver involvement is still unclear. To
|Collections||ANU Research Publications|
|Source:||Journal of Molecular Endocrinology|
|01_Da Paz Filho_Molecular_pathways_involved_in_2013.pdf||524.64 kB||Adobe PDF||Request a copy|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.